Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
FDA Removes GHK-Cu from Category 2: What Peptide Users Need to Know On April 15, 2026, the FDA announced a significant regulatory update: injectable GHK-Cu (copper tripeptide-1) will be removed from the Category 2 bulk substances list by July 2026
Regulatory Support : Suppliers should assist with dossier preparation for international markets
They reported higher plasma levels of NOx metabolites (nitrates and nitrites) in 22 children with chronic spontaneous urticaria
Therapeutic Research 56 (7), 656670
Inflammation control This peptide doesnt just mask pain: it genuinely tackles inflammation at its source
Think Sharper
US$ 26.14
US$ 25.45
US$ 28.25
US$ 26.18
US$ 27.33
US$ 26.94
US$ 26.41
